Mostrando 10 resultados de: 19
Filtros aplicados
Subtipo de publicación
Article(19)
Área temáticas
Enfermedades(15)
Medicina y salud(12)
Salud y seguridad personal(8)
Problemas sociales y servicios a grupos(6)
Farmacología y terapéutica(5)
Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study
ArticleAbstract: Background: Dietary guidelines recommend minimising consumption of whole-fat dairy products, as theyPalabras claves:Autores:Alhabib K.F., Anand S.S., Avezum A.J., Boström K.B., Chifamba J., Dans A.M., Deeraili A., Dehghan M., Gupta R., Hu B., Iqbal R., Khatib R., Kumar R., Lanas F.T., Lear S.A., Mente A., Mohammadifard N., Mohan V., Mony P.K., Mozaffarian D., Noorhassim I., Oguz A., Orlandini A., PATRICIO LOPEZ -JARAMILLO, Poirier P., Rangarajan S., Rozanska D., Sheridan P., Teo K.K., Tsolkile L.P., Varma R.P., Wei L., Wentzel-Viljoen E., Yeates K.E., Yin L., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusAssociations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies
ArticleAbstract: Background Several studies reported a U-shaped association between urinary sodium excretion and cardPalabras claves:Autores:Anand S.S., Avezum A.J., Bahonar A., Chifamba J., Dagenais G.R., DIaz R., Iqbal R., Lanas F., Lear S.A., Li W., Lu Y., Mann J.F.E., McQueen M.J., Mente A., Mony P.K., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rensheng L., Rosengren A., Schutte A.E., Szuba A., Teo K.K., Yi S., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusAlcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: A prospective cohort study
ArticleAbstract: Summary Background Alcohol consumption is proposed to be the third most important modifiable risk faPalabras claves:Autores:Avezum A.J., Chifamba J., Dagenais G.R., DIaz R., Jian B., Kumar R., Lear S.A., Leong D.P., Mckee M., Mohan V., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rana P., Rangarajan S., Rosengren A., Schutte A.E., Seron P., Smyth A., Szuba A., Teo K.K., Wei L., Yang W., Yusuf S., Zhang X.Fuentes:googlescopusFruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
ArticleAbstract: Background The association between intake of fruits, vegetables, and legumes with cardiovascular disPalabras claves:Autores:Agapay D., Altuntas Y., Anand S.S., Auger D., Avezum A.J., Azad A.K., Bangdiwala S.I., Bo H., Bonneville N., Casaccia G., Cayer M., Cherry H.M., Chifamba J., Choudhury T., Chunming C., Corber E., Cuneo J.M., Dagenais G.R., De Bluts A.L.B., de Jong V., Dehghan M., Dejesus J., DIaz R., Elsheikh W., Fodor G.J., Gasevic D., Gupta R., Haque R., Hassan I., Heldman L., Hongye Z., Iqbal R., Jian B., Kay I., Khan M.U., Khatib R., Kutty V.R., Lana F., Lanas F., Lear S.A., Li W., Linetsky B., Liu J., Liu L., Liu X., Mannan A., Marcilio C.S., Martinez S., Mattos A.C., Mente A., Miller V., Mohammadifard N., Mohan V., Noorhassim I., Oliveira G.B.F., Oliveros M.J., Orlandini A., Parvin S., PATRICIO LOPEZ -JARAMILLO, Peer N., Pipe A., Poirier P., Proulx M.C., Rabbani K.A., Rahman O., Ramezani E., Rangarajan S., Rimac J., Rosengren A., Schutte A.E., Seron P., Shane A., Sintaha M., Solano R., Swaminathan S., Talukdar A.T., Teo K.K., Tongana T., Tooheen R.B., Toscanelli S., Trottier S., Turbide G., Valdebenito A., Vukmirovich I., Wei L., Wenhua Z., Wentzel-Viljoen E., Wielgosz A., Xiaohong C., Xingyu W., Xiuwen Z., Xuan J., Yi S., Yin L., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M., Zatońska K., Zhang X.Fuentes:googlescopusGlobal and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
ArticleAbstract: Background Stroke is a leading cause of death and disability, especially in low-income and middle-inPalabras claves:Autores:Agapay S., Al Hussain F., Avezum A.J., Chin S.L., Czlonkowska A., Damasceno A., Dans A.M., Dehghan M., DIaz R., Diener H.C., ElSayed A., Ferguson J., Hankey G.J., Iqbal R., Iversen H.K., Lanas F., Langhorne P., Liu L., Magazi D., Málaga G., McQueen M.J., Mondo C.K., Nilanont Y., Ogah O.S., Ogunniyi A., Oguz A., Oveisgharan S., O’Donnell M., Pais P., Paré G., PATRICIO LOPEZ -JARAMILLO, Peñaherrera E., Pogosova N., Rangarajan S., Rao-Melacini P., Rosengren A., Rumboldt Z., Ryglewicz D., Wang X., Weimar C., Xavier D., Yusoff K., Yusuf S., Yusufali A.M., Zhang H., Zhang X.Fuentes:googlescopusFixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
ArticleAbstract: Background: In randomised controlled trials, fixed-dose combination treatments (or polypills) have bPalabras claves:Autores:Avezum A.J., Bangdiwala S.I., Bosch J.J., Castellano J.M., Dagenais G.R., Dans A.M., DIaz R., Fuster V., Gamra H., Gao P., Huffman M.D., Joseph P.G., Liu L., Lonn E.M., Malekzadeh R., Pais P., PATRICIO LOPEZ -JARAMILLO, Prabhakaran D., Rodgers A., Roshandel G., Sliwa K., Teo K.K., Xavier D., Yusuf S., Zhu J.Fuentes:googlescopusDulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
ArticleAbstract: Background: Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascularPalabras claves:Autores:Abella M., Alebuena A., Almagro S., Amoroso E., Anadon P., Andreu E., Aristimuño G., Arzadun M., Atisso C.M., Avezum A.J., Barbieri M., Barcudi R., BARTOLACCI I.P., Basile J.N., Bolobanich G., BORDONAVA A.P., Bustamante Labarta M., Bustos B., CACCAVO A., Camino A., Cantero M., Cardona-Munoz E.G., Carignano M., CARTASEGNA L.U.I.S., Chung N., Cipullo M., Colhoun H.M., Commendatore V., Conget I., Conosciuto V., Costamagna O., Crespo C., Cuello J.L., Cuneo C.A., Cushman W.C., Cusimano S., Dagenais G.R., Dean S., DIaz R., Dituro C., Dominguez A., Dyal L., Farah M., Fernandez A., Fernandez F., Ferrari A., Flammia P., Franek E., Fuentealba J., Gallardo K.B., Garcia C., GARCIA DURAN R.O., GARRIDO M., Gavicola R., Gerbaudo C., Gerstein H.C., Gilli G., Giotto A.P., Godoy Bolzán P., Gomez Vilamajo O., Guerlloy F., Guridi C., Gutierrez Garrido N., Hall S., Hâncu N., Hanefeld M., HASBANI E., Hermida S., Holt S., HOMINAL M.A., HRABAR A., Ingaramo A., Izzicupo A., Jansky P., Keltai M., Krynski M., Lagrutta M., Lakshmanan M., Lanas F.T., Lanchiotti P., Langhe M., Leiter L.A., Leonard V., Llanos J., López-Santi R., Pais P., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Rao-Melacini P., Raubenheimer P.J., Riddle M.C., Riesmeyer J.S., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T., Washington Stalin García Cuenta, Wong G., Xavier D.Fuentes:googlescopusDulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
ArticleAbstract: Background: Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal outcomes in people wPalabras claves:Autores:Abella M., Alebuena A., Almagro S., Amoroso E., Anadon P., Andreu E., Aristimuño G., Arzadun M., Atisso C.M., Avezum A.J., Barbieri M., Barcudi R., BARTOLACCI I.P., Basile J.N., Bolobanich G., BORDONAVA A.P., Botros F.T., Bustamante Labarta M., Bustos B., CACCAVO A., Camino A., Cantero M., Cardona-Munoz E.G., Carignano M., CARTASEGNA L.U.I.S., Chung N., Cipullo M., Colhoun H.M., Commendatore V., Conget I., Conosciuto V., Costamagna O., Crespo C., Cuello J.L., Cuneo C.A., Cushman W.C., Cusimano S., Dagenais G.R., Dean S., DIaz R., Dituro C., Dominguez A., Dyal L., Farah M., Fernandez A., Fernandez F., Ferrari A., Flammia P., Franek E., Fuentealba J., Gallardo K.B., Garcia C., GARCIA DURAN R.O., GARRIDO M., Gavicola R., Gerbaudo C., Gerstein H.C., Gilli G., Giotto A.P., Godoy Bolzán P., Gomez Vilamajo O., Guerlloy F., Guridi C., Gutierrez Garrido N., Hall S., Hâncu N., Hanefeld M., HASBANI E., Hermida S., Holt S., HOMINAL M.A., HRABAR A., Ingaramo A., Izzicupo A., Jansky P., Keltai M., Krynski M., Lagrutta M., Lakshmanan M., Lanas F.T., Lanchiotti P., Langhe M., Leiter L.A., Leonard V., Llanos J., López-Santi R., Pais P., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Rao-Melacini P., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T., Washington Stalin García Cuenta, Wong G., Xavier D.Fuentes:googlescopusEffects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial
ArticleAbstract: Background: Trials of β blockers in patients undergoing non-cardiac surgery have reported conflictinPalabras claves:Autores:Aggarwala R., Alonso-Coello P., Argibay-Poliquin E., Avezum A.J., Badner N., Baer C., Baidel Y., Baptista M., Barratt S., Beattie W.S., Bednarowski M., Beilby D., Bertozzi H.A., Berwanger O., Blacher C., Bodanese L.C., Boisvenu G., Bolsin S., Boulton A., Boyd D., Brunet D., Bryson G.L., Bugler S., Burlingham J., Caccavo R.A., Campeau J., Campos De Albuquerque D., Carlos Zevallos J., Chan M.T.V., Choi P., Chrolavicius S., Ciapponi A., Cope L., Devereaux P.J., Do Amara Baruzzi A.C., Douglas J., Esteves J.P., Faller J., Fatovich S., Ferrari A., Foëx P., França Neto O.R., Gannedahl P., Garcia Dieguez M., Giles J., Goldman L., Grant J., Greenspan L., Guiselli Gallina L.E., Guyatt G.H., Halliwell R., Hudson R.J., Islas Andrade S., Izukawa N.M., Jacka M.J., Kallas F.C., Keltai M., Kerr Saraiva J.F., Kerridge R.K., Leino K., Leslie K., Liu L., Love J., Málaga G., March S., Marin-Neto J.A., Mauricio Espinel, McCulloch T.J., Montori V.M., Myles P.S., Nicolosi L.N., Nigro Maia L., Paech M., Pais P., Penha Rosateli P.H., Peyton P., Phrommintikul A., Pogue J., Poole C., Poustie S., Priestly M., Rabello R., Raeder J., Reeves M., Salazar A., Schammass Ducatti T., Schricker T., Sear J., Sierra F., Tesolin P., Tristan M., Urŕutia G., Wallace S., Warriner B., Weitkamp B., Wolfers D., Xavier D., Xu S., Yang H., Yusuf S.Fuentes:scopusMetabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study
ArticleAbstract: Background: There is a paucity of data on the prevalence of risk factors and their associations withPalabras claves:Autores:Abdul-Razak S., Alhabib K.F., Anand S.S., Avezum A.J., Breet Y., Chifamba J., DIaz R., Gupta R., Hu B., Iqbal R., Ismail R., Kelishadi R., Khatib R., Lang X., Li S., Mohan V., Oguz A., Palileo-Villanueva L.M., PATRICIO LOPEZ -JARAMILLO, Pinnaka L.V.M., Poltyn-Zaradna K., R S.P., Rangarajan S., Rosengren A., Seron P., Sharief W.M., Teo K.K., Verghese S.T., Walli-Attaei M., Wielgosz A., Yeates K.E., Yusuf R., Yusuf S.Fuentes:googlescopus